Literature DB >> 16174001

Comparison of blue dye and isotope with blue dye alone in breast sentinel node biopsy.

David B Y Syme1, John P Collins, G Bruce Mann.   

Abstract

BACKGROUND: Sentinel lymph node biopsy (SNB) is rapidly gaining acceptance as an alternative to axillary dissection (AD) in patients with early breast cancer. Debate continues regarding the optimum technique for sentinel node (SN) mapping. We have used our series of 364 SNBs to compare two different techniques.
METHODS: A retrospective review of patients undergoing SNB by surgeons in our breast service. Overall results were analysed, with particular attention to those having blue dye alone and those having blue dye in combination with radio-labelled colloid. SNs were analysed using haematoxylin-eosin and immunohistochemical staining.
RESULTS: SN identification rates were similar: 96% for dye alone and 89% for dye and colloid in combination. Twenty-one per cent of SN mapped with dye alone contained metastases, compared to 30% with dye and colloid in combination. The false-negative rate was correspondingly higher in the dye alone group (21 vs 2.8%).
CONCLUSION: SNB using dye and colloid in combination was significantly superior to dye alone in this series. We advocate using both dye and colloid for intraoperative SN mapping.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16174001     DOI: 10.1111/j.1445-2197.2005.03531.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  8 in total

1.  How long will I be blue? Prolonged skin staining following sentinel lymph node biopsy using intradermal patent blue dye.

Authors:  Metehan Gumus; Hatice Gumus; Sue E Jones; Peter A Jones; Ali R Sever; Jennifer Weeks
Journal:  Breast Care (Basel)       Date:  2013-06       Impact factor: 2.860

2.  Long-term follow-up results of fluorescence and blue dye guided sentinel lymph node biopsy in early breast cancer.

Authors:  Chaobin Wang; Fuzhong Tong; Yingming Cao; Peng Liu; Bo Zhou; Hongjun Liu; Lin Cheng; Miao Liu; Jiajia Guo; Fei Xie; Houpu Yang; Siyuan Wang; Yuan Peng; Shu Wang
Journal:  Breast Cancer Res Treat       Date:  2021-03-24       Impact factor: 4.872

3.  Breast Cancer Sentinel Node Detection: An Alternative Solution for Centers Lacking Nuclear Technology.

Authors:  Mahmoud A Alhussini; Ahmed T Awad; Mohamed H Ashour; Ahmed Abdelateef; Haytham Fayed
Journal:  Breast Care (Basel)       Date:  2016-08-15       Impact factor: 2.860

4.  Assessment of Intraparenchymal Injection of 1% Patent Blue Dye in the Upper Outer Quadrant of the Breast to Identify Sentinel Lymph Node in Early Retro-Areolar Breast Cancer in Women: A Tertiary Centre Experience in Egypt.

Authors:  Mina M B Fouad; Kirilos Fouad; Sandy M N Ibraheim
Journal:  World J Surg       Date:  2022-01-07       Impact factor: 3.352

5.  Sentinel lymph node mapping with patent blue dye in patients with breast cancer: a retrospective single institution study.

Authors:  Fabrice Olivier; Audrey Courtois; Veronique Jossa; Gaelle Bruck; Samy Aouachria; Michel Coibion; Guy Jerusalem
Journal:  Gland Surg       Date:  2021-09

6.  Histologic evaluation of sentinel and non-sentinel axillary lymph nodes in breast cancer by multilevel sectioning and predictors of non-sentinel metastasis.

Authors:  Piyarat Jeeravongpanich; Tuenjai Chuangsuwanich; Chulaluk Komoltri; Adune Ratanawichitrasin
Journal:  Gland Surg       Date:  2014-02

7.  Sentinel lymph node biopsy mapped with methylene blue dye alone in patients with breast cancer: A systematic review and meta-analysis.

Authors:  Jiyu Li; Xiao Chen; Ming Qi; Yanshuang Li
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

8.  Factors that affect the false negative rate of sentinel lymph node mapping with methylene blue dye alone in breast cancer.

Authors:  Huang Li; Zhang Jun; Ge Zhi-Cheng; Qu Xiang
Journal:  J Int Med Res       Date:  2019-09-11       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.